Chip stocks fall with Nvidia after data center rev disappointment
LONDON - Octopus Investments Limited has reduced its stake in veterinary services provider CVS Group PLC (LSE:CVSG) to 5.99% of voting rights, according to a regulatory filing released Tuesday.
The London-based investment firm now holds 4,298,964 voting rights in CVS Group, down from its previous position of 6.98%. The threshold was crossed on Monday, July 14, with the company notifying CVS Group of the change the following day.
According to the standard form for notification of major holdings submitted to the London Stock Exchange (LON:LSEG), Octopus Investments holds its stake through indirect voting rights. The firm does not hold any additional voting rights through financial instruments.
The filing indicates that Octopus Investments is controlled by Octopus Capital Limited, which is listed as the ultimate controlling entity in the ownership chain.
The notification was made in accordance with UK regulatory requirements that mandate investors to disclose when their holdings cross certain thresholds in publicly listed companies.
CVS Group operates as one of the UK’s leading providers of integrated veterinary services, with operations across the UK, Ireland, and the Netherlands.
The information was disclosed in a regulatory news service (RNS) filing to the London Stock Exchange.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.